Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telemedicine keeps Newfoundland airwaves buzzing

P Rich

    Medical Group Management
    |August 9, 1983
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dermatologists' knowledge of dermoscopic features in hair and nail disorders.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2022
    Same author

    Development and validation of the Physician's Global Assessment of Fingernail Psoriasis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study.

    The British journal of dermatology·2019
    Same author

    Normal neuroanatomical variants that may be misinterpreted as disease entities.

    Clinical radiology·2017
    Same author

    Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2016